NCT05578287 2023-12-07
DETECT
Sun Yat-sen University
Phase 2 Unknown
Clinical Trials
3 trialsNCT05493683 2022-10-21
Disitamab Vedotin Combined With Tislelizumab in Advanced HER2 Positive Colorectal Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Unknown
NCT05333809 2022-04-20
Pembrolizumab and Disitamab Vedotin in HER2-expressing Metastatic Colorectal Cancer
Shanghai Zhongshan Hospital
Phase 2 Unknown